Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-07-13 00:11 | 2013-07-11 | ET | N/A | SALESFORCE COM INC | 10% owner | Other | BUY | $33.75 | 73,626,481 | $2,484,893,734 | 0 | +100.0% |
| 2013-07-12 00:25 | 2013-07-09 | ACHN | N/A | QVT Associates GP LLC | 10% owner | Other | BUY | $6.33 | 390,944 | $2,475,223 | 13,964,554 | +2.9% |
| 2013-07-12 00:01 | 2013-07-09 | CO | N/A | MCCARTHY KENT C | 10% owner, Other | Other | BUY | $2.91 | 366,782 | $1,066,639 | 8,268,506 | +4.6% |
| 2013-07-10 00:03 | 2013-07-05 | DVA | DAVITA INC. | WESCHLER, R. TED | Other | Services-Misc Health & Allied Services, NEC | BUY | $114.01 | 110,309 | $12,576,053 | 15,723,415 | +0.7% |
| 2013-07-09 23:30 | 2013-07-05 | ACHN | N/A | QVT Associates GP LLC | 10% owner | Other | BUY | $6.28 | 642,509 | $4,036,306 | 13,573,610 | +5.0% |
| 2013-07-09 23:51 | 2013-07-05 | DVA | DAVITA INC. | BERKSHIRE HATHAWAY INC | 10% owner | Services-Misc Health & Allied Services, NEC | BUY | $114.01 | 110,309 | $12,576,053 | 15,723,415 | +0.7% |
| 2013-07-09 23:25 | 2013-07-09 | ACCL | N/A | RGM Capital, LLC | 10% owner | Other | BUY | $8.64 | 184,569 | $1,594,270 | 5,908,822 | +3.2% |
| 2013-07-09 02:04 | 2013-07-02 | PETX | N/A | Avalon Ventures IX, L.P. | 10% owner | Other | BUY | $6.00 | 500,000 | $3,000,000 | 4,170,545 | +13.6% |
| 2013-07-08 21:59 | 2013-07-05 | IREIT | Inland Real Estate Income Trust, Inc. | GOODWIN DANIEL L | Director, Officer, 10% owner - Chairman | Real Estate Investment Trusts | BUY | $9.00 | 111,111 | $1,000,000 | 237,948 | +87.6% |
| 2013-07-05 23:42 | 2013-07-02 | DVA | DAVITA INC. | WESCHLER, R. TED | Other | Services-Misc Health & Allied Services, NEC | BUY | $114.78 | 639,200 | $73,369,485 | 15,613,106 | +4.3% |
| 2013-07-06 00:06 | 2013-07-02 | ACHN | N/A | QVT Associates GP LLC | 10% owner | Other | BUY | $6.43 | 1,963,248 | $12,615,832 | 12,931,101 | +17.9% |
| 2013-07-05 23:37 | 2013-07-02 | DVA | DAVITA INC. | BERKSHIRE HATHAWAY INC | 10% owner | Services-Misc Health & Allied Services, NEC | BUY | $114.78 | 639,200 | $73,369,485 | 15,613,106 | +4.3% |
| 2013-07-03 16:16 | 2013-07-02 | SWZ | Total Return Securities Fund | HOTTINGER CAPITAL CORP | Other | Other | BUY | $12.31 | 113,285 | $1,394,266 | 127,937 | +773.2% |
| 2013-07-03 01:56 | 2013-06-27 | FKWL | FRANKLIN WIRELESS CORP | Jyoung Joon Won | Director, 10% owner | Telephone & Telegraph Apparatus | BUY | $1.40 | 800,493 | $1,120,690 | 1,340,662 | +148.2% |
| 2013-07-02 21:56 | 2013-07-01 | AGCO | AGCO Corporation | SRINIVASAN MALLIKA | Director | Farm Machinery & Equipment | BUY | $49.87 | 37,198 | $1,855,064 | 669,321 | +5.9% |
| 2013-07-03 00:08 | 2013-07-02 | PETX | N/A | Vander Vort John | Director, 10% owner | Other | BUY | $6.00 | 500,000 | $3,000,000 | 4,351,050 | +13.0% |
| 2013-07-02 23:55 | 2013-07-01 | ESPR | Esperion Therapeutics, Inc. | DOMAIN PARTERS VII L P | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 280,923 | $3,932,922 | 2,066,935 | +15.7% |
| 2013-07-02 23:51 | 2013-07-01 | ESPR | Esperion Therapeutics, Inc. | Halak Brian K | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 285,714 | $3,999,996 | 35,253 | +100.0% |
| 2013-07-03 00:46 | 2013-07-01 | N/A | N/A | Douglas Robert A. S. | Director | Other | BUY | $8.15 | 1,840,491 | $15,000,002 | 1,840,491 | +100.0% |
| 2013-07-02 23:15 | 2013-07-02 | ACN | Accenture plc | ROHLEDER STEPHEN J | Officer - Group Chief Exec-Health & PS | Services-Business Services, NEC | BUY | $71.99 | 20,000 | $1,439,748 | 20,000 | +100.0% |
| 2013-07-02 23:40 | 2013-07-01 | ESPR | Esperion Therapeutics, Inc. | SCHOEMAKER KATHLEEN K | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 285,714 | $3,999,996 | 35,253 | +100.0% |
| 2013-07-02 23:48 | 2013-07-01 | ESPR | Esperion Therapeutics, Inc. | DOVEY BRIAN H | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 285,714 | $3,999,996 | 35,253 | +100.0% |
| 2013-07-02 23:31 | 2013-07-01 | ESPR | Esperion Therapeutics, Inc. | VITULLO NICOLE | Director, 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 285,714 | $3,999,996 | 35,253 | +100.0% |
| 2013-07-03 00:06 | 2013-07-02 | PETX | N/A | MPM BIOVENTURES V, L.P. | 10% owner | Other | BUY | $6.00 | 500,000 | $3,000,000 | 4,351,050 | +13.0% |
| 2013-07-03 00:03 | 2013-07-01 | ESPR | Esperion Therapeutics, Inc. | BLAIR JAMES C | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 285,714 | $3,999,996 | 35,253 | +100.0% |
| 2013-07-02 23:35 | 2013-07-01 | ESPR | Esperion Therapeutics, Inc. | TREU JESSE I | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 285,714 | $3,999,996 | 35,253 | +100.0% |
| 2013-07-01 23:40 | 2013-07-01 | ESPR | Esperion Therapeutics, Inc. | Longitude Capital Partners, LLC | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 216,676 | $3,033,464 | 38,011 | +100.0% |
| 2013-07-02 02:50 | 2013-07-01 | NSTG | N/A | Clarus Lifesciences II, L.P. | 10% owner | Other | BUY | $10.00 | 750,000 | $7,500,000 | 3,959,440 | +23.4% |
| 2013-07-01 23:28 | 2013-06-26 | RNGE | RING ENERGY, INC. | McCabe Stanley Myron | Director | Crude Petroleum & Natural Gas | BUY | $5.50 | 545,000 | $2,997,500 | 2,191,502 | +33.1% |
| 2013-07-01 23:36 | 2013-07-01 | ESPR | Esperion Therapeutics, Inc. | ENRIGHT PATRICK G | Director, 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 216,676 | $3,033,464 | 38,011 | +100.0% |
| 2013-07-01 23:34 | 2013-07-01 | ESPR | Esperion Therapeutics, Inc. | JANNEY DANIEL | Director | Pharmaceutical Preparations | BUY | $14.00 | 235,714 | $3,299,996 | 2,052,189 | +13.0% |
| 2013-07-01 23:33 | 2013-07-01 | ESPR | Esperion Therapeutics, Inc. | Alta Partners VIII, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 235,714 | $3,299,996 | 2,052,189 | +13.0% |
| 2013-07-01 23:33 | 2013-07-01 | ESPR | Esperion Therapeutics, Inc. | Aisling Capital II LP | 10% owner | Pharmaceutical Preparations | BUY | $14.00 | 238,119 | $3,333,666 | 2,054,594 | +13.1% |
| 2013-07-01 23:37 | 2013-07-01 | ESPR | Esperion Therapeutics, Inc. | GOLDSTEIN DOV A MD | Director | Pharmaceutical Preparations | BUY | $14.00 | 238,119 | $3,333,666 | 2,054,594 | +13.1% |
| 2013-07-02 04:17 | 2013-06-28 | DUNR | N/A | BlueMountain Capital Management, LLC | 10% owner | Other | BUY | $1.60 | 2,600,625 | $4,161,000 | 464,253 | +100.0% |
| 2013-07-02 04:16 | 2013-06-28 | DUNR | N/A | BlueMountain GP Holdings, LLC | 10% owner | Other | BUY | $1.60 | 1,526,427 | $2,442,283 | 1,401,134 | +100.0% |
| 2013-06-28 21:07 | 2013-06-25 | TELOZ | N/A | Rimmer Nancy | 10% owner | Other | BUY | $23,595.00 | 6,979 | $164,669,505 | 767,941 | +0.9% |
| 2013-06-28 21:10 | 2013-06-25 | TELOZ | N/A | RNR Production Land & Cattle Company, Inc | 10% owner | Other | BUY | $23,595.00 | 6,979 | $164,669,505 | 767,941 | +0.9% |
| 2013-06-28 21:28 | 2013-06-25 | TELOZ | N/A | RIMMER ROY T JR | 10% owner | Other | BUY | $23,595.00 | 6,979 | $164,669,505 | 767,941 | +0.9% |
| 2013-06-29 00:52 | 2013-06-25 | PTCT | PTC THERAPEUTICS, INC. | Koppel Adam | Director | Pharmaceutical Preparations | BUY | $15.00 | 1,250,000 | $18,750,000 | 2,333,333 | +115.4% |
| 2013-06-28 20:36 | 2013-06-25 | PTCT | PTC THERAPEUTICS, INC. | HBM Healthcare Investments (Cayman) Ltd. | 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 666,676 | $10,000,140 | 2,508,171 | +36.2% |
| 2013-06-28 23:11 | 2013-04-09 | N-A | N/A | Medical Information Technology, Inc. Profit Sharing Trust | 10% owner | Other | BUY | $90,392.30 | 5,810 | $525,179,250 | 5,434,932 | +0.1% |
| 2013-06-27 18:57 | 2013-06-25 | ZINC | N/A | Dalal Street, LLC | 10% owner | Other | BUY | $12.00 | 212,553 | $2,549,977 | 5,168,264 | +4.3% |
| 2013-06-28 00:52 | 2013-06-25 | SNTA | MADRIGAL PHARMACEUTICALS, INC. | Kovner Bruce | Director, 10% owner | Pharmaceutical Preparations | BUY | $4.53 | 500,000 | $2,265,400 | 2,950,000 | +20.4% |
| 2013-06-28 04:35 | 2013-06-25 | PTCT | PTC THERAPEUTICS, INC. | SCHMERTZLER MICHAEL | Director, 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 533,333 | $7,999,995 | 1,297,369 | +69.8% |
| 2013-06-28 04:31 | 2013-06-25 | PTCT | PTC THERAPEUTICS, INC. | ALDRICH RICHARD | Director | Pharmaceutical Preparations | BUY | $15.00 | 766,667 | $11,500,005 | 300,000 | +100.0% |
| 2013-06-26 20:01 | 2013-06-24 | ZINC | N/A | Dalal Street, LLC | 10% owner | Other | BUY | $11.87 | 193,757 | $2,300,806 | 4,955,711 | +4.1% |
| 2013-06-27 00:02 | 2013-06-24 | SPW | SPX Technologies, Inc. | RELATIONAL INVESTORS LLC | 10% owner | Metalworkg Machinery & Equipment | BUY | $71.10 | 232,103 | $16,502,732 | 6,645,691 | +3.6% |
| 2013-06-25 23:57 | 2013-06-21 | SMLP | N/A | SUMMIT MIDSTREAM PARTNERS HOLDINGS, LLC | Director, 10% owner | Other | BUY | $31.53 | 3,107,698 | $97,985,718 | 14,691,397 | +26.8% |
| 2013-06-26 00:22 | 2013-06-21 | ZINC | N/A | Dalal Street, LLC | 10% owner | Other | BUY | $12.06 | 173,092 | $2,088,165 | 4,761,954 | +3.8% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.